Crystal arthropathies
Georgios Filippou, MD, PhD
IRCCS Galeazzi - Sant'Ambrogio Hospital
Milan, Milan, Italy
Disclosure(s): No relevant disclosure to display
Tristan Pascart, MD, PhD
Lille Catholic University
Lille, France
Disclosure(s): No financial relationships with ineligible companies to disclose
Sara Tedeschi, MD, MPH
Brigham and Women's Hospital
Boston, MA, United States
Disclosure(s): Novartis: Consultant (Terminated, March 1, 2023)
Building on recent calcium pyrophosphate deposition (CPPD) disease classification criteria and recent randomized clinical trials, this session will focus on the use of ultrasound for diagnosis of, and phenotypic description and clinical care decision-making for, patients with CPPD. New therapeutics for the management of acute and chronic manifestations of CPPD will be reviewed. Finally, the risk factors for cardiovascular disease for patients with CPPD will be discussed.
Speaker: Georgios Filippou, MD, PhD – IRCCS Galeazzi - Sant'Ambrogio Hospital
Speaker: Sara Tedeschi, MD, MPH – Brigham and Women's Hospital
Speaker: Tristan Pascart, MD, PhD – Lille Catholic University